Research Article: Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial
Introduction:
Interstitial lung disease (ILD) is a heterogeneous group of non-neoplastic and non-infectious diseases that affect the lung parenchyma. It is characterized by an initial inflammation of the pulmonary alveoli that extends to the interstitium and beyond, leading to diffuse pulmonary fibrosis. These lesions could cause a decrease in lung capacity, diffusing function, and disturbance of the ventilation–perfusion ratio, ultimately resulting in hypoxemia and respiratory failure. ILD can be divided into known-causes ILD…
Read more